Indoleamine 2,3-dioxygenase 1 (IDO1) is upregulated in different types of cancers including lung cancers, ovarian cancers, prostate cancers, colon cancers, breast cancers, and kidney cancers (95). Here, IDO1 is linked to prostate carcinoma.